Synthesis 2002(8): 1027-1032
DOI: 10.1055/s-2002-31949
PAPER
© Georg Thieme Verlag Stuttgart · New York

Chiral Preparation of C 2-Symmetric 4-Cyclopentene-1,3-diol

Seiko Kimura, Ryoko Ehama, Kohei Inomata*
Tohoku Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan
Fax: +81(22)2752013; e-Mail: inomata@tohoku-pharm.ac.jp;
Further Information

Publication History

Received 5 February 2002
Publication Date:
03 June 2002 (online)

Abstract

Optically pure C2 -symmetric 4-cyclopentene-1,3-diol has been prepared in both enantiomeric forms from racemic (3aS*,4R*,7S*,7aS*)-3a,4,7,7a-tetrahydro-4,7-methano-1H-inden-1-one by employing lipase-mediated kinetic resolution as the key step. As a result, the known (3aS*,4R*,7S*,7aS*)-3a,4,7,7a-tetrahydro-4,7-methano-1H-inden-1-one is transformed into (1′S*,3′S*,3′aR*,4′S*,7′R*,7′aS*)- 2′,3′,3′a,4′,7′,7′a-hexahydro-3′-hydroxy-4′,7′-methano-1′H-inden-1′-yl benzoate, via stereo- and regioselective hydride reduction of epoxy ketone and sequential benzoylation, which is resolved under transesterification conditions in the presence of lipase. The hydride reduction of benzoate and acetate gives the corresponding chiral diols, which are further transformed into both enantiomers of C2 -symmetric 4-cyclopentene-1,3-diol via a retro-Diels-Alder reaction.

11

Preliminary results of this work were presented at The 5 th International Symposium on Biocatalysis and Biotransformation, Darmstadt: Germany, September 2-7, 2001, see abstracts p. 353.

15

All of the lipases we used were commercially available from Amano Enzyme Inc., Japan. The origin of each lipase is summarized in the Table.